Compare FOLD & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOLD | SONO |
|---|---|---|
| Founded | 2002 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.2B |
| IPO Year | 2007 | 2018 |
| Metric | FOLD | SONO |
|---|---|---|
| Price | $9.92 | $18.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $30.29 | $17.00 |
| AVG Volume (30 Days) | ★ 4.6M | 1.6M |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $598,704,000.00 | ★ $1,443,276,000.00 |
| Revenue This Year | $21.12 | $4.35 |
| Revenue Next Year | $21.23 | $7.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 21.28 | N/A |
| 52 Week Low | $5.51 | $7.63 |
| 52 Week High | $10.57 | $19.08 |
| Indicator | FOLD | SONO |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 64.83 |
| Support Level | $9.56 | $18.16 |
| Resistance Level | $10.05 | $19.08 |
| Average True Range (ATR) | 0.37 | 0.65 |
| MACD | -0.02 | 0.21 |
| Stochastic Oscillator | 51.14 | 89.27 |
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.